Lydia Newton @lsnewton - Bluesky Profile

Latest posts by lsnewton.bsky.social on Bluesky

Huge congratulations Che! Well done!

10.07.2025 13:17 — 👍 1 🔁 0 💬 0 📌 0

Blizard Institute welcomes world-leading team of virologists

We are delighted to be joining the Blizard Institute in Autumn. The Blizard Institute is an amazing place for discovery science and we're looking forward to more transformative research and collaborations.

www.qmul.ac.uk/blizard/abou...

10.07.2025 13:05 — 👍 24 🔁 7 💬 2 📌 2

Towers Lab attending @londoninfectionecr.bsky.social (LINE) annual symposium. Great talk lineups at the Francis Crick Institute, London. #LINE #ScienceIsCool.

09.06.2025 12:42 — 👍 9 🔁 3 💬 0 📌 0

Virtual Virology is back - our first ever phage session. Do join us...

08.05.2025 18:09 — 👍 22 🔁 12 💬 2 📌 3

Microbiology and infectious diseases This page highlights recent articles on all aspects of bacteriology, mycology, parasitology and virology, covering the biology of pathogens, host-pathogen ...

Great seeing our recent antiviral PROTAC paper chosen by Nature Comms Editors as one of the 50 best papers in Microbiology and Infectious Diseases!

www.nature.com/collections/...

05.03.2025 16:16 — 👍 10 🔁 2 💬 0 📌 0

Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV - Nature Communications Targeted protein degradation has so far been rarely applied as an antiviral strategy. Here, the authors report that macrocycle-based PROTACs targeting host protein cyclophilin A, exploited during vira...

Antiviral drug development:

Small molecules inducing degradation of host protein cyclophilin A show #antiviral activity against HIV-1 & HCV

@towerslab.bsky.social ‬ @lsnewton.bsky.social @claragathmann.bsky.social
@jollylab.bsky.social @alessiociulli.bsky.social

www.nature.com/articles/s41...

28.02.2025 15:01 — 👍 11 🔁 3 💬 0 📌 0

Thanks to all involved - @towerslab.bsky.social @claragathmann.bsky.social @katemorling.bsky.social @akreuschl.bsky.social @jollylab.bsky.social @alessiociulli.bsky.social & others!

14.02.2025 15:32 — 👍 2 🔁 0 💬 0 📌 0

My PhD work is now published!

We designed PROTACs that degrade the viral cofactor CypA and demonstrated their antiviral activity against HIV & HCV. We anticipate broad efficacy against unrelated viruses and reduced evolution of viral resistance. They also make excellent tools to probe Cyp biology.

14.02.2025 13:25 — 👍 20 🔁 2 💬 2 📌 0

Today @gogs-k.bsky.social, @tlhr.bsky.social, and I are launching @bindresearch.org, a UK-based not-for-profit research startup to deliver publicly–available tools and datasets to make intrinsically disordered proteins druggable. 🍝 💊🧲 💻 🦠

11.02.2025 09:26 — 👍 75 🔁 20 💬 3 📌 1

@lsnewton is following 20 prominent accounts

@ziqizhou

Caro Goujon
@carogoujon

Virologist (Inserm) and group leader at IRIM (@irim-life.bsky.social), Montpellier University, CNRS. RNA viruses and innate immunity. #FirstGen. Views my own.

Che Colpitts
@colpittsc

Assistant professor at Queen's University | Molecular virology | RNA viruses | Virus-host interactions Lab website: https://colpittslab.com

Priya
@pkatesuppiah

Emma Wall
@dremmacbw

Clinician Scientist #infectiousdisease #COVID19 @TheCrick @UCLHResearch @uclh @HTropDis @UCLInfectImm Passionate about health & vaccine equity

Hashim Ali
@ali-hashim

Blizard Institute, Queen Mary University of London
@blizardinstitute

Queen Mary University of London
@qmul

Queen Mary University of London is one of the UK's leading research universities, a place where difference leads to greatness.

Center for Immunology of Viral Infections (CiViA)
@civia-aarhus

Center of Excellence at Aarhus University (@au.dk) & TU Munich (@tum.de), focused on discovering novel #immune response mechanisms against #viral #infections. Funded by Danmarks Grundforsk Fond (@dg.dk). https://biomed.au.dk/civia

Arbovirus seminars
@arbovirus

virtual seminars on arbovirus biology, by the community for the community (organised by Tem Morrison, @tulilab.bsky.social and @clive-mckimmie.bsky.social

Clive McKimmie
@clive-mckimmie

Team leader of the Virus Host Interaction Team University of York, Skin Research Centre; 🇬🇧🇪🇺🏳️‍🌈 (he/him) co-chairs @Arbovirus seminars. #immunology #virology #skin #vectors Website https://www.hyms.ac.uk/about/people/Clive-McKimmie

London Infection Network for/by ECRs (LINE)
@londoninfectionecr

We are a London-based network for scientific & social exchange among Early Career Researchers interested in Infection Biology. Run by ECRs for ECRs. 👩‍🔬🧫🧬 (Formerly LIPN)

Gabriele Pollara
@gpollara

Infectious Diseases doctor (at UCLH) and academic (at UCL). Research focuses on immune responses to TB and leprosy, but I'm also involved in too many other projects I probably shouldn't be...

Ben Hale
@benhale

Professor of Medical Virology, University of Zurich, Switzerland. My research group studies molecular mechanisms of the interferon system, interferon deficiencies, and viral disease.

Guido Papa
@guipap

Incoming Group Leader at the University of Milan🇮🇹 Interested in #viral replication factories and Targeted Protein Degradation #TPD 🧬🦠🔬Previous MRC-LMB @mrclmb.bsky.social🇬🇧, University of Cambridge @uniofcam.bsky.social🇬🇧 and ICGEB-Trieste🇮🇹

Abhi Das
@adas1

50:50 physician scientist Infectious diseases/microbiology/penicillin allergy de-labelling Fledgling lab studying immune perturbations in paediatric infections at UCL

Ashwanth C. Francis
@ashwanthfrancis

Asst. Professor of Biological Sciences Imaging All things Viruses @Florida State University

Blair Strang
@strangviruslab

City St George's, University of London. HCMV, anti-viral drugs, placental infection, transmission, etc etc etc. #JGV Editoral Board. Views my own.

Alessio Ciulli
@alessiociulli

Professor, Founder and Director of the Centre for Targeted Protein Degradation at the University of Dundee. We develop molecules that induce protein interactions and degradation

Jeremy Luban 🧬🦠🔬🩺🎸🎻
@lubanlab

Scientist/Professor/Physician/Musician Serendipity & absurdity